InnoGene Co

InnoGene Co Assets per Share

The Total Assets per Share of InnoGene Co (344860.KQ) as of Oct 16, 2026 is 1,467.26 KRW. In the previous year, Total Assets per Share was 1,438.41 KRW — a change of 2.01% (higher).

Assets per Share

1,467.26KRW

YoY

2.01%

Last updated:

Total Assets per Share of InnoGene Co is 2024 1,467.26 KRW. Total Assets per Share of InnoGene Co was 2023 1,438.41 KRW. It decreases by 2.01% higher compared to the previous year.

The InnoGene Co Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2018
416.73 KRW
Jan 1, 2019
368.85 KRW
Jan 1, 2020
367.14 KRW
Jan 1, 2021
557.60 KRW
Jan 1, 2022
664.79 KRW
Jan 1, 2023
1,438.41 KRW
Jan 1, 2024
1,467.26 KRW
The InnoGene Co Assets per Share history
YEARAssets per ShareYoY
1,467.26KRW+2.01%
1,438.41KRW+116.37%
664.79KRW+19.22%
557.60KRW+51.88%
367.14KRW-0.46%
368.85KRW-11.49%
416.73KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

InnoGene Co Stock analysis

What does InnoGene Co do? InnoGene Co Ltd is a company based in Seoul, South Korea, operating within the Consumer Staples sector and the Consumer products industry. The company has 77 employees and went public on April 27, 2020. Its website is http://www.innogene.com/. InnoGene focuses on research and development related to skin regeneration and anti-aging solutions, utilizing stem cell technology and fusion technology. The company develops and manufactures cosmetics aimed at skin regeneration and aging control. Additionally, InnoGene is involved in the manufacturing and distribution of medical devices. The company's primary activities revolve around creating products that address skin health and aging concerns, leveraging scientific research in stem cell applications. As a publicly traded entity, InnoGene operates under the ticker symbol 344860.KQ and is registered with the ISIN KR7344860002. The company's headquarters are located in Seoul, and it serves a market that values innovative skincare and medical device solutions. InnoGene's product portfolio includes both cosmetic and medical device offerings, targeting consumers interested in advanced skincare technologies. The company's operations are centered on research-driven development to enhance skin health and combat aging effects. InnoGene Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about InnoGene Co stock

Total Assets per Share of InnoGene Co is 1,467.26 KRW in 2024.

Total Assets per Share of InnoGene Co changed from 1,438.41 KRW to 1,467.26 KRW, representing a 2.01% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share InnoGene Co since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — InnoGene Co

All Key Metrics — InnoGene Co